Antidepressants During Pregnancy

Are Antidepressants Safe to Take During Pregnancy?

Antidepressants are not one uniform group, so safety depends on the specific medicine, dose, stage of pregnancy, treatment history, and severity of the underlying condition. Selective serotonin reuptake inhibitors, or SSRIs, have been studied more extensively in pregnancy than many other psychiatric medicines. Available evidence has not established a large overall increase in major congenital abnormalities with the most commonly used SSRIs, although individual medicines may carry different considerations.

The American College of Obstetricians and Gynecologists advises clinicians not to withhold or discontinue psychiatric medication solely because of pregnancy or breastfeeding. Someone who has remained well on a particular medicine may face a meaningful risk of relapse after stopping it. Clinicians therefore consider previous episodes, past treatment responses, coexisting health conditions, other medications, and the patient's preferences before recommending continuation, adjustment, or a carefully supervised taper.

What Risks Can Antidepressant Exposure Pose to a Baby?

Some newborns exposed to SSRIs or similar antidepressants near delivery develop temporary symptoms such as jitteriness, feeding difficulty, altered muscle tone, or breathing problems. Often described as poor neonatal adaptation, these symptoms are generally short-lived but may require observation after birth. Research has also examined uncommon outcomes such as persistent pulmonary hypertension of the newborn, although estimating medication-specific risk is difficult because maternal illness and other factors can influence outcomes.

Pregnancy studies are usually observational because randomized medication trials involving pregnant participants are rarely appropriate. This makes it challenging to separate the effects of a medicine from depression severity, smoking, substance use, chronic disease, or inadequate prenatal care. A reported association does not automatically prove that an antidepressant caused an outcome, and absolute risk is generally more useful to patients than relative risk alone.

Why Can Stopping an Antidepressant During Pregnancy Be Harmful?

Untreated depression during pregnancy can impair sleep, nutrition, daily functioning, relationships, and engagement with prenatal care. Severe or recurrent illness may also involve self-harm or suicide risk. Protecting maternal mental health is therefore part of protecting pregnancy health, rather than a competing concern that can be considered separately from fetal well-being.

Abruptly stopping an antidepressant can produce discontinuation symptoms and may increase the chance that the original condition returns. Patients who are pregnant, planning pregnancy, or concerned about medication exposure should contact their prescriber before changing a dose. A shared plan may include continuing the current treatment, gradual dose adjustment, psychotherapy, closer symptom monitoring, and coordination between mental health and maternity-care professionals.